Industry Insights

  1. 'How Do You Feel?': Designing A Cardiac Trial With A Patient-Reported Primary Endpoint 8/21/2026

    Imbria Pharmaceuticals' Albert Kim, MD, Ph.D., shares why PROs are the point of the company's FORTITUDE-HCM trial for patients with non-obstructive hypertrophic cardiomyopathy.

  2. The Reality Of Clinical Research Federal Funding Cuts 8/20/2026

    Although the most catastrophic federal funding cuts didn't come to fruition, Pamela Garzone discusses where some impacts are being felt now and will be felt for years to come.

  3. Building The Execution Architecture For Real-World Data To Have Real-World Impact 8/20/2026

    RWE's next challenge is execution. Learn how life sciences orgns can turn evidence into sustained business and clinical impact.

  4. Stock Options: Choosing The Right Viral Inoculum For An Early-Phase Norovirus Trial 8/20/2026

    Viral stock can make or break a norovirus challenge study. Cocrystal Pharma's Sam Lee explains why inoculum quality, infectivity, and availability matter.

  5. Running Compliant Studies Without Enterprise EDC Overhead 8/19/2026

    Low-complexity medical device and IVD studies often fall between enterprise EDC systems and spreadsheets. This webinar shows how a compliant, audit-ready alternative works in practice.

  6. From Hype To Health: The Three Jobs Sword Made Its Clinical Evidence Do 8/19/2026

    A long-term strategy for turning clinical evidence into clinician trust, standard-of-care status, and payer reimbursement for digital care.

  7. Everyone Is A Consultant Now 8/19/2026

    Jon Newton argues clinical research’s “vanishing middle” is giving rise to a more flexible workforce of consultants, specialists, and boutique firms.

  8. Rare Disease Study Gets A Boost From Crowdsourced Patient Reported Data 8/18/2026

    Jen A. Levitt, MD, explains how crowdsourced patient-reported data and AI tools can compress rare disease research timelines and surface new signals.

  9. Challenges And Opportunities In Lung Cancer Clinical Development 8/17/2026

    Discover how precision medicine and novel therapeutics reshape lung cancer clinical development. Gain insights to overcome modern trial execution and global enrollment challenges.

  10. Clinical Trial Logistics: What Biopharma Needs To Prepare For Next 8/17/2026

    Fragmented clinical trial logistics are slowing programs and increasing risk. Learn how coordinated planning and digital visibility are becoming competitive advantages in complex, global studies.